Last reviewed · How we verify
NCT06587477
Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors
trial testing Hormonal profile in Cancer, Treatment-Related in 200 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 16 January 2023 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- Hormonal profile — full drug profile →
- Semen analysis
- Questionnaire
Conditions studied
- Cancer, Treatment-Related — all drugs for Cancer, Treatment-Related →
- Late Effect — all drugs for Late Effect →
- Semen Analysis — all drugs for Semen Analysis →
Sponsor
The University of Hong Kong
Who can join
Adults 18 to 50, male only, with Cancer, Treatment-Related or Late Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cancer treatment can affect the testicular function, including sperm and hormonal functions. The aim of this study is to assess the testicular function and semen quality in young men who recover from childhood and adolescent cancer in Hong Kong. This can provide more information for pre-treatment counselling as well as improve post treatment survivorship care. The testicular function will be compared to aged-matched controls from men attending the Family Planning Association for premarital check-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06587477
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer, Treatment-Related
Currently open trials in the same condition.
- NCT07141056 — The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study · recruiting
- NCT06975384 — The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer · recruiting
- NCT05492136 — Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? · NA · recruiting
- NCT06269198 — Postoperative Complications in Cancer Patients Monitored With Intelligent Continuous Monitoring System · NA · recruiting
- NCT06653478 — Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagn · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06587477 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06587477.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing